Page last updated: 2024-08-23

lithium and Melanoma

lithium has been researched along with Melanoma in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (11.11)	29.6817
2010's	4 (44.44)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Guttuso, T	1
Kawada, T	1
Asgari, MM; Chien, AJ; Fireman, B; Quesenberry, CP; Tsai, AL	1
Bugi-Marteyn, A; Daali, Y; Liaudet, N; Merat, R; Py, C; Schwärzler, C; Wrobel, LJ	1
Wu, S; Xia, Y	1
de Prost, Y; Dubertret, L; Guillaume, JC; Revuz, J; Touraine, R	1
Aladjem, M; Ballin, A; Banyash, M; Barzilay, Z; Boichis, H; Gal, R; Witz, IP	1
Harker, YD; Harmon, F; Kudchadker, RJ; Lee, CL; Zhou, XL	1
Fuchs, A; Malik, Z; Nordenberg, J; Novogrodsky, A; Panet, C; Stenzel, KH; Wasserman, L	1

Reviews

1 review(s) available for lithium and Melanoma

Article	Year
High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity. Medical hypotheses, 2019, Volume: 131 Topics: alpha-Synuclein; Alzheimer Disease; Autophagy; beta Catenin; beta-Glucosidase; Brain Chemistry; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Incidence; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lithium; Lithium Carbonate; Melanoma; Models, Biological; Mutation; Neuroprotective Agents; Nicotiana; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Parkinsonian Disorders; Smokers; Water; Wnt Signaling Pathway	2019

Article

Year

High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.

Medical hypotheses, 2019, Volume: 131

Topics: alpha-Synuclein; Alzheimer Disease; Autophagy; beta Catenin; beta-Glucosidase; Brain Chemistry; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Incidence; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lithium; Lithium Carbonate; Melanoma; Models, Biological; Mutation; Neuroprotective Agents; Nicotiana; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Parkinsonian Disorders; Smokers; Water; Wnt Signaling Pathway

2019

Other Studies

8 other study(ies) available for lithium and Melanoma

Article	Year
High lithium levels in tobacco, incidences of Parkinson's disease and melanoma: Mechanism of the association. Medical hypotheses, 2020, Volume: 143 Topics: Humans; Incidence; Lithium; Melanoma; Nicotiana; Parkinson Disease	2020
Association between Lithium Use and Melanoma Risk and Mortality: A Population-Based Study. The Journal of investigative dermatology, 2017, Volume: 137, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; California; Cause of Death; Disease Progression; Female; Follow-Up Studies; Humans; Incidence; Lithium; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; SEER Program; Skin Neoplasms; Survival Rate; Young Adult	2017
Drug-induced expression of the RNA-binding protein HuR attenuates the adaptive response to BRAF inhibition in melanoma. Biochemical and biophysical research communications, 2019, 09-17, Volume: 517, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; ELAV-Like Protein 1; Gene Expression Regulation, Neoplastic; Humans; Lithium; Melanoma; Mice; Molecular Targeted Therapy; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Up-Regulation	2019
Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells. Cell cycle (Georgetown, Tex.), 2015, Volume: 14, Issue:11 Topics: Axin Protein; beta Catenin; Cell Proliferation; Fluorescent Antibody Technique; Gene Expression Regulation; Humans; Immunoblotting; Lithium; Melanoma; Models, Biological; Real-Time Polymerase Chain Reaction; Signal Transduction; Tissue Inhibitor of Metalloproteinase-2; Ubiquitination	2015
[Present status of dermatology]. La Revue du praticien, 1980, Nov-21, Volume: 30, Issue:53 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Eruptions; Female; Humans; Leg Ulcer; Lithium; Male; Melanoma; Penicillamine; Psoriasis; Skin Diseases; Skin Neoplasms	1980
The effect of lithium chloride on tumour appearance and survival of melanoma-bearing mice. British journal of cancer, 1983, Volume: 48, Issue:1 Topics: Animals; Bleomycin; Chlorides; Drug Therapy, Combination; Female; Leukocyte Count; Lithium; Lithium Chloride; Melanoma; Mice; Mice, Inbred C57BL; Necrosis; Neoplasms, Experimental; Time Factors; Vinblastine	1983
A Monte Carlo dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for accelerator boron neutron capture therapy. Medical physics, 2000, Volume: 27, Issue:1 Topics: Beryllium; Biophysical Phenomena; Biophysics; Boron Neutron Capture Therapy; Glioblastoma; Humans; Lithium; Melanoma; Monte Carlo Method; Photons; Radioisotopes; Radiotherapy Planning, Computer-Assisted	2000
The anti-proliferative effect of lithium chloride on melanoma cells and its reversion by myo-inositol. British journal of cancer, 1987, Volume: 55, Issue:1 Topics: Animals; Cell Differentiation; Cell Division; Cell Line; Chlorides; Clone Cells; Humans; Inositol; Lithium; Lithium Chloride; Melanoma; Mice; Mice, Inbred C57BL; NADH Dehydrogenase; Neoplasm Transplantation	1987